Tarsus Pharmaceuticals, Inc.
TARS· Nasdaq
Released May 1, 2025, after the close
10-Q filed May 1, 2025, 31 days after period end · 0001819790-25-000078
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $78.34M | $27.61M | $2.50M | $539.00K |
| Net Income | -$25.12M | -$35.73M | -$23.42M | -$20.24M |
| EPS Diluted |
Tarsus Pharmaceuticals, Inc. · CIK 1819790 · Engraved from SEC EDGAR
| -$0.64 |
| -$1.01 |
| -$0.88 |
| -$0.98 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.